Brief: Upstream Bio Reports Q3 2024 Financial Results And Recent Business Highlights
Nov 7 (Reuters) - Upstream Bio Inc UPB.O :
* UPSTREAM BIO REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
* UPSTREAM BIO INC: QTRLY NET LOSS $16.0 MILLION
Source text: ID:nGNX6YqD6K
Further company coverage: UPB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Upstream Bio
See all newsUpstream Bio Q2 net loss narrows slightly on lower R&D costs
Upstream Bio Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
Brief: Upstream Bio To Showcase Additional Efficacy Data From The Phase 2 Vibrant Trial Of Verekitug In Crswnp In Oral Session At Eaaci 2026
Upstream Bio Q1 net loss widens on higher R&D costs